Literature DB >> 8738168

Glucocorticoid upregulation of glutamate dehydrogenase gene expression in vitro in astrocytes.

H Hardin-Pouzet1, P Giraudon, M F Belin, M Didier-Bazes.   

Abstract

Glutamate, the major excitatory neurotransmitter, is preferentially catabolized in astrocytes by glutamate dehydrogenase (GDH). Treatment of an astrocytic cell line with hydrocortisone (10(-5) M) resulted in increased expression of GDH mRNA. Transfection of the cells with truncated parts of the GDH promoter showed that genomic responsive elements activated by hydrocortisone are localized in the -557/+1 region of the promoter. This control of GDH expression by glucocorticoids may be involved in their protective effect against glutamate excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738168     DOI: 10.1016/0169-328x(95)00327-o

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  4 in total

1.  Glucocorticoid treatment of astrocytes results in temporally dynamic transcriptome regulation and astrocyte-enriched mRNA changes in vitro.

Authors:  Bradley S Carter; Fan Meng; Robert C Thompson
Journal:  Physiol Genomics       Date:  2012-10-30       Impact factor: 3.107

2.  Effect of dexamethasone treatment on maturational changes in the NMDA receptor in sheep brain.

Authors:  J E McGowan; G Sysyn; K H Petersson; G B Sadowska; O P Mishra; M Delivoria-Papadopoulos; B S Stonestreet
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

3.  Imbalanced expression of glutamate-glutamine cycle enzymes induced by human T-cell lymphotropic virus type 1 Tax protein in cultivated astrocytes.

Authors:  H Akaoka; H Hardin-Pouzet; A Bernard; B Verrier; M F Belin; P Giraudon
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  Effects of dexamethasone on K(+)-evoked glutamate release from rat hippocampal slices.

Authors:  Nektaria Ioannou; Charis Liapi; Constantine E Sekeris; George Palaiologos
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.